Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy.
Tufail
A
A
Weisz
J M
JM
Holland
G N
GN
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000209:etiology / Q000382:microbiology; D002408:Catheters, Indwelling / Q000009:adverse effects; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy* / Q000209:etiology; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects*; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D015774:Ganciclovir